Milestone in medical innovation by Uppaluri clinic
Uppaluri K&H Personalized Medicine Clinic Pvt Ltd Successfully Unveils AI platform for big data analytics and drug discovery GeneConnectRx, Marking a Milestone in Medical Innovation
Hyderabad, India – January 5th, 2024 – Uppaluri K&H Personalized Medicine Clinic Pvt Ltd proudly presents GeneConnectRx, an innovative AI platform launched by GenepoweRx, the diagnostic wing of K&H clinic. This revolutionary step in personalized medicine marks a paradigm shift, empowering healthcare providers to customize treatments based on individual genetic makeup.
The launch ceremony at our Hyderabad headquarters welcomed luminaries and industry leaders, underscoring the transformative potential of GeneConnectRx.
Esteemed Guests:
Padma Bhushan Dr. D Nageshwar Reddy, Chairman and Chief of Gastroenterology at AIG Hospitals, contributed invaluable expertise.
Mr. Penmetsa Venkata Subba Raju, Vice Chairman of AIG Hospitals, endorsed the platform’s vision for personalized healthcare.
Prof. Ch Mohan Rao, CSIR – Distinguished Scientist and Former Director, Centre for Cellular & Molecular Biology (CCMB), emphasized technology’s role in personalized medicine.
Drs. Kalyan Uppaluri and Hima J Challa, founders of K&H clinics and pioneers behind GeneConnectRx, unveiled the platform, marking a new era in medical research.
GeneConnectRx represents the collaborative efforts of a multidisciplinary team comprising computational scientists, molecular biologists, bioinformaticians, and chemoinformaticians. Over two years, this team identified drug targets for complex medical conditions.
Dr. Nageshwar Reddy commented, “Personalized medicine must become standard practice in every hospital. Focused research in this space is crucial to provide accurate, effective, and affordable personalized medicine products to all individuals.”
Dr. Vinayender Tulla added, “GeneConnectRx holds the potential to revolutionize drug discovery by decoding genetic information, enabling targeted and personalized therapies for more effective treatments.”
“GeneConnectRx is poised to revolutionize AI-based drug discovery, propelling precision medicine. Our ongoing efforts focus on validating drug targets for Brain Cancer, Monogenic Diabetes, Parkinson’s disease, High Cholesterol, and Autism. Our process patent application reflects our dedication to innovation,” expressed Dr. Kalyan Uppaluri from GenepoweRx.
“Our collaboration with AIG Hospitals has resulted in groundbreaking initiatives like AIG’s pharmacogenomics study. GeneConnectRx integrates internal data, global resources, and cutting-edge models to forecast potential molecules for revolutionary drug discovery,” highlighted Dr. Hima Challa.
Ultimately, GeneConnectRx serves as the bridge connecting genetic data to diseases, identifying targets, and paving the way for potential cures.
About Uppaluri K&H Personalized Medicine Clinic Pvt Ltd: Uppaluri K&H Personalized Medicine Clinic Pvt Ltd is committed to pioneering revolutionary advancements in healthcare through its subsidiary, GeneConnectRx. The company aims to translate genetic insights into tangible therapeutic outcomes, promising to address the root causes of various medical conditions.
[…] Source link […]